His fiance convinced him to see a doctor, and after months of tests he was diagnosed with paroxysmal nocturnal hemoglobinuria (PNH), the first disease Soliris was approved to treat.
FORBES: How A $440,000 Drug Is Turning Alexion Into Biotech's New Innovation Powerhouse